SYNGENE
Syngene International Limited
Each stock's 10,000-path forecast, rendered as light.
Syngene International Limited (SYNGENE) Stock Analysis & Case Study
Is SYNGENE a good buy? The data-driven verdict.
Syngene International Limited (SYNGENE) trades at ₹400,on the numbers it tread carefully, a Downstox Snapshot Score of 33/100.
On the numbers, Syngene International Limited (SYNGENE) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 54.5× earnings, ROE of 7.8%, a 59% model probability of trading higher in a year. Below: the full bull case, bear case, sector-relative valuation, and a probability-weighted price target for 2027-2031.
Last updated . Data snapshot for research, not investment advice.
SYNGENE fundamentals at a glance, PE, PB, ROE, ROCE, market cap, dividend yield
How SYNGENE ranks against the 2,373 companies in our screener
- SYNGENE's market cap of 16,296 Cr ranks in the 82nd percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYNGENE's book value of ₹120 ranks in the 57th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYNGENE's promoter holding of 52.6% ranks in the 37th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYNGENE's 3-year profit (PAT) growth of -8.0% ranks in the 21st percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYNGENE's 3-year revenue growth of 5.0% ranks in the 35th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYNGENE's debt-to-equity ratio of 0.09x is lower than 79% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
Is SYNGENE overvalued? SYNGENE P/E vs peers
SYNGENE trades at 54.5× earnings. We don't have a verified sector peer group for this stock yet, so no sector peer median or peer comparison table is shown here. Showing one anyway would compare it against an arbitrary set of large-cap names, not real sector peers.
SYNGENE share price target 2027, 2028, 2029, 2030, 2031, a probability view
Unlike a single guessed number, this is a probability-weighted range from a 10,000-path Monte-Carlo simulation on 9.8y of SYNGENE history (7%/yr drift, 31%/yr volatility).
| Year | Low (P10) | Median target (P50) | High (P90) | Upside vs today |
|---|---|---|---|---|
| SYNGENE 2027 | ₹289 | ₹435 | ₹654 | +8% |
| SYNGENE 2028 | ₹264 | ₹469 | ₹833 | +16% |
| SYNGENE 2029 | ₹254 | ₹506 | ₹1,007 | +25% |
| SYNGENE 2030 | ₹248 | ₹545 | ₹1,199 | +35% |
| SYNGENE 2031 | ₹243 | ₹588 | ₹1,424 | +46% |
Median (P50) is the central estimate; the P10-P90 band is the 80% confidence range. Probabilities, not promises.
What is the probability SYNGENE goes up, or doubles?
The bull case for SYNGENE
- Syngene International Limited is part of the nifty200 universe with live, tracked fundamentals on Downstox.
- Upside scenario: the model's optimistic (P90) 3-year path reaches ₹1,007.
The bear case & risks
- SYNGENE's P/E of 55.0x is lower than 24% of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- SYNGENE's return on equity of 7.8% ranks in the 39th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.
- Downside scenario: the model's pessimistic (P10) 3-year path falls to ₹254.
SYNGENE volatility & expected range, how bumpy is the ride?
Over the last 9.8 years SYNGENE compounded at 7%/year with annualized volatility of 31%. That volatility implies a 1-year 80% range of ₹289-₹654, the honest backbone behind any single price target.
SYNGENE price forecast, the full 60-month probability fan
SYNGENE price probability fan
Each band shows where 10,000 simulated paths land. The wider the fan, the more uncertainty.
Probability of key outcomes
What are the odds SYNGENE hits common targets within the simulated horizon?
Full multi-horizon detail on the SYNGENE price target & forecast page.
SYNGENE Piotroski F-Score: 5/8, how financially strong is it?
The Piotroski F-Score grades financial strength on profitability, leverage and efficiency checks. Downstox scores the eight checks it can verify from published filings, so 8 is full marks. SYNGENE scores 5/8, mixed financial health.
SYNGENE MTF margin & leverage across 11 brokers
Margin Trading Facility lets you buy SYNGENE with part of the capital. Lower margin % = higher leverage. Rates compared across 11 brokers (no competitor publishes this):
| Broker | Margin required | Approx. leverage |
|---|---|---|
| Upstox | 30.48% | 3.3× |
| ZerodhaCHEAPEST | 30.45% | 3.3× |
| Groww | 30.52% | 3.3× |
| Dhan | 30.45% | 3.3× |
| Kotak Neo | 30.49% | 3.3× |
| Paytm Money | 40.48% | 2.5× |
| Pocketful | 30.52% | 3.3× |
| Fyers | 31.25% | 3.2× |
| Anand RathiCHEAPEST | 30.45% | 3.3× |
| Bajaj Broking | 32.00% | 3.1× |
| Share India | 30.52% | 3.3× |
Compare every broker on the SYNGENE MTF page.
About Syngene International Limited: sector, index & market-cap context
Syngene International Limited (SYNGENE) is a small-cap NSE-listed company, and a constituent of the Nifty 500 index, with a market capitalisation of ₹16,151 Cr. See more stocks on our screener.
How the SYNGENE Snapshot Score & forecast are built
The Downstox Snapshot Score is a transparent, rules-based read of Syngene International Limited's public fundamentals plus a statistical forecast, not an analyst opinion. It rewards low-to-fair valuation, high ROE/ROCE, a strong Piotroski F-Score, a dividend, low volatility and a favourable probability of upside; it penalises rich valuations, weak capital efficiency, a low F-Score and high volatility. The price target is a 10,000-path Monte-Carlo simulation on real historical volatility, a distribution, not a single guess. The bull and bear cases are generated from the same data, so you always see both sides.
This is information, not investment advice. Do your own due diligence and consult a SEBI-registered adviser before investing.
SYNGENE analysis, FAQs
Is Syngene International Limited (SYNGENE) a good buy?
On the numbers, Syngene International Limited (SYNGENE) tread carefully, a Downstox Snapshot Score of 33/100, weighing expensive at 54.5× earnings, ROE of 7.8%, a 59% model probability of trading higher in a year. This is a data snapshot for research, not investment advice.
Is SYNGENE overvalued or undervalued?
SYNGENE trades at 54.5× earnings, expensive versus the ~22× long-run Nifty average.
What is the SYNGENE share price target for 2031?
SYNGENE's probability-weighted 2031 median target is ₹588, with an 80% range of ₹243-₹1,424 (10,000-path Monte-Carlo).
What is the probability SYNGENE doubles in 5 years?
The modelled probability of SYNGENE reaching ₹807 (2×) within 5 years is 32%.
What is the bull case for SYNGENE?
Syngene International Limited is part of the nifty200 universe with live, tracked fundamentals on Downstox.
What are the risks in SYNGENE?
SYNGENE's P/E of 55.0x is lower than 24% of the 2,373 NSE companies in our screener, as of 9 Aug 2026. SYNGENE's return on equity of 7.8% ranks in the 39th percentile of the 2,373 NSE companies in our screener, as of 9 Aug 2026.